Asserter profile

VERMEER MANUFACTURING COMPANY

operating company3 patents now3 ever0 cases filed during tenure1 connections

PTAB exposure

3of this entity’s patents have been challenged at PTAB (3 total proceedings). 2 had claims invalidated.

Final written decisions are public record. The invalidation grounds usually carry over as § 102 / § 103 ammunition in district court — see IPR estoppel.

Two-hop network

Edges marked ⚖️ overlap with at least one infringement suit filed during the receiving entity’s tenure with the patent. Bold-bordered = this entity. Red = NPE; orange = shell LLC; green = defensive aggregator; blue = operating company.

flowchart LR
    Nvermeer_manufacturing["VERMEER MANUFACTURING COMPANY"]
    Nlangenfeld_greg_thomas_brad_hartke_louis_hutchinson_matt["LANGENFELD, GREG; THOMAS, BRAD; HARTKE,…"]
    Nvermeer_manufacturing_iowa["Vermeer Manufacturing Company, Iowa"]
    Nlangenfeld_greg_thomas_brad_hartke_louis_hutchinson_matt -->|"2022 · Assignment · 12098063"| Nvermeer_manufacturing
    Nlangenfeld_greg_thomas_brad_hartke_louis_hutchinson_matt -->|"2015 · Assignment of Assignors Interest · 11465891"| Nvermeer_manufacturing
    Nlangenfeld_greg_thomas_brad_hartke_louis_hutchinson_matt -->|"2016 · Assignment · 9975750"| Nvermeer_manufacturing
    Nlangenfeld_greg_thomas_brad_hartke_louis_hutchinson_matt -->|"2015 · Assignment · 9321386"| Nvermeer_manufacturing_iowa
    classDef focal fill:#fef3c7,stroke:#92400e,stroke-width:3px,color:#1c1917
    classDef npe fill:#fee2e2,stroke:#be123c,stroke-width:2px,color:#1c1917
    classDef shell fill:#fed7aa,stroke:#9a3412,stroke-width:2px,color:#1c1917
    classDef defensive fill:#dcfce7,stroke:#15803d,stroke-width:2px,color:#1c1917
    classDef operating fill:#e0f2fe,stroke:#075985,stroke-width:1px,color:#1c1917
    class Nvermeer_manufacturing focal
    class Nvermeer_manufacturing_iowa operating

Patents currently held (3)

Connected entities (1)

Correspondent attorneys (1)

Attorneys / firms recorded with USPTO when this entity received a patent. Recurrence is the signal — many firms do both NPE and operating-company patent work, so a single appearance doesn’t mean much.